Magdalena Gorska
Concepts (352)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Estradiol | 6 | 2016 | 476 | 2.550 |
Why?
| Asthma | 21 | 2022 | 2159 | 2.370 |
Why?
| Osteosarcoma | 5 | 2016 | 71 | 2.110 |
Why?
| Vehicle Emissions | 3 | 2020 | 69 | 1.780 |
Why?
| Nitric Oxide Synthase Type I | 3 | 2015 | 26 | 1.560 |
Why?
| Adaptor Proteins, Signal Transducing | 8 | 2012 | 394 | 1.560 |
Why?
| Th2 Cells | 8 | 2020 | 164 | 1.560 |
Why?
| Killer Cells, Natural | 4 | 2020 | 381 | 1.510 |
Why?
| Maternal Exposure | 4 | 2020 | 142 | 1.460 |
Why?
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 4 | 2021 | 21 | 1.090 |
Why?
| Bone Neoplasms | 3 | 2016 | 199 | 0.980 |
Why?
| Interleukin-17 | 4 | 2020 | 105 | 0.910 |
Why?
| Lactams, Macrocyclic | 2 | 2013 | 47 | 0.880 |
Why?
| Benzoquinones | 2 | 2013 | 44 | 0.870 |
Why?
| Prenatal Exposure Delayed Effects | 2 | 2020 | 468 | 0.810 |
Why?
| Antineoplastic Agents | 4 | 2016 | 1974 | 0.770 |
Why?
| Granzymes | 1 | 2020 | 40 | 0.750 |
Why?
| Mutation, Missense | 2 | 2012 | 300 | 0.740 |
Why?
| Oxidative Stress | 6 | 2016 | 1179 | 0.700 |
Why?
| Lymphocytes | 5 | 2021 | 347 | 0.680 |
Why?
| Protein Tyrosine Phosphatases | 5 | 2016 | 145 | 0.630 |
Why?
| Bronchial Hyperreactivity | 5 | 2015 | 95 | 0.620 |
Why?
| Chaperonin 60 | 2 | 2016 | 14 | 0.620 |
Why?
| Heat-Shock Proteins | 2 | 2016 | 129 | 0.590 |
Why?
| Mice | 23 | 2022 | 15528 | 0.590 |
Why?
| Antibiotics, Antineoplastic | 2 | 2016 | 114 | 0.580 |
Why?
| Signal Transduction | 13 | 2021 | 4713 | 0.570 |
Why?
| Estrogen Antagonists | 1 | 2016 | 39 | 0.560 |
Why?
| Estrogen Receptor beta | 1 | 2016 | 37 | 0.550 |
Why?
| DNA Breaks | 1 | 2015 | 2 | 0.540 |
Why?
| Apoptosis | 6 | 2016 | 2484 | 0.530 |
Why?
| Mitochondrial Proteins | 2 | 2016 | 226 | 0.530 |
Why?
| Bacterial Outer Membrane Proteins | 4 | 2016 | 58 | 0.530 |
Why?
| Allergens | 6 | 2022 | 425 | 0.520 |
Why?
| Antineoplastic Agents, Hormonal | 1 | 2016 | 143 | 0.520 |
Why?
| Intracellular Signaling Peptides and Proteins | 6 | 2021 | 404 | 0.520 |
Why?
| Neuroblastoma | 1 | 2016 | 135 | 0.520 |
Why?
| Interleukin-1beta | 1 | 2017 | 379 | 0.520 |
Why?
| Cell Line, Tumor | 8 | 2016 | 2851 | 0.510 |
Why?
| Virus Diseases | 1 | 2017 | 198 | 0.500 |
Why?
| Protein Processing, Post-Translational | 5 | 2016 | 408 | 0.500 |
Why?
| Receptors, Antigen, T-Cell | 2 | 2011 | 634 | 0.490 |
Why?
| Neurodegenerative Diseases | 1 | 2016 | 99 | 0.480 |
Why?
| Leukocyte Common Antigens | 4 | 2015 | 76 | 0.480 |
Why?
| Hippocampus | 2 | 2015 | 735 | 0.480 |
Why?
| Animals | 28 | 2022 | 33399 | 0.470 |
Why?
| Cell Survival | 8 | 2016 | 1047 | 0.450 |
Why?
| CD4-Positive T-Lymphocytes | 4 | 2021 | 985 | 0.450 |
Why?
| Neoplasm Proteins | 1 | 2016 | 401 | 0.440 |
Why?
| Lymphopenia | 1 | 2012 | 48 | 0.440 |
Why?
| T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2011 | 7 | 0.420 |
Why?
| HSP90 Heat-Shock Proteins | 1 | 2012 | 45 | 0.420 |
Why?
| Inflammation | 2 | 2017 | 2571 | 0.420 |
Why?
| Disease Models, Animal | 8 | 2022 | 3730 | 0.410 |
Why?
| Neoplasms | 2 | 2016 | 2179 | 0.410 |
Why?
| Cell Proliferation | 9 | 2021 | 2275 | 0.410 |
Why?
| Lymphocyte Activation | 6 | 2021 | 1067 | 0.400 |
Why?
| Drug Screening Assays, Antitumor | 3 | 2016 | 189 | 0.360 |
Why?
| Air Pollutants | 1 | 2013 | 316 | 0.360 |
Why?
| Interleukin-13 | 3 | 2020 | 135 | 0.360 |
Why?
| rab GTP-Binding Proteins | 2 | 2010 | 64 | 0.360 |
Why?
| Immunological Synapses | 1 | 2009 | 18 | 0.350 |
Why?
| Cell Differentiation | 4 | 2020 | 1753 | 0.350 |
Why?
| Ovalbumin | 3 | 2022 | 165 | 0.340 |
Why?
| Humans | 45 | 2021 | 119032 | 0.340 |
Why?
| Hydrogen Peroxide | 4 | 2015 | 305 | 0.340 |
Why?
| Mitogen-Activated Protein Kinase 3 | 5 | 2021 | 155 | 0.320 |
Why?
| Cytokines | 6 | 2020 | 1900 | 0.320 |
Why?
| Interleukin-5 | 2 | 2008 | 31 | 0.300 |
Why?
| Capillary Permeability | 1 | 2007 | 140 | 0.290 |
Why?
| Dynamin II | 1 | 2006 | 8 | 0.280 |
Why?
| Mice, Inbred BALB C | 5 | 2022 | 1206 | 0.280 |
Why?
| Aurintricarboxylic Acid | 2 | 2016 | 3 | 0.280 |
Why?
| Immunity, Innate | 4 | 2021 | 745 | 0.280 |
Why?
| Bronchoalveolar Lavage | 2 | 2018 | 89 | 0.280 |
Why?
| Mice, Knockout | 6 | 2021 | 2680 | 0.270 |
Why?
| Respiratory Tract Diseases | 1 | 2007 | 143 | 0.270 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 2 | 2015 | 9 | 0.270 |
Why?
| T-Lymphocytes | 4 | 2009 | 1774 | 0.260 |
Why?
| Th17 Cells | 2 | 2016 | 57 | 0.260 |
Why?
| Immunoglobulin E | 3 | 2018 | 366 | 0.260 |
Why?
| Dose-Response Relationship, Drug | 4 | 2016 | 1947 | 0.250 |
Why?
| Mice, Inbred C57BL | 7 | 2021 | 4914 | 0.250 |
Why?
| Transforming Growth Factor beta | 4 | 2012 | 462 | 0.250 |
Why?
| Cell Death | 2 | 2016 | 339 | 0.240 |
Why?
| Jurkat Cells | 5 | 2015 | 134 | 0.240 |
Why?
| Disease Susceptibility | 2 | 2017 | 331 | 0.230 |
Why?
| Bronchoalveolar Lavage Fluid | 3 | 2022 | 613 | 0.230 |
Why?
| Gene Expression Regulation | 4 | 2015 | 2446 | 0.230 |
Why?
| Cells, Cultured | 7 | 2020 | 4081 | 0.230 |
Why?
| NF-kappa B | 1 | 2007 | 670 | 0.230 |
Why?
| MAP Kinase Signaling System | 4 | 2021 | 293 | 0.220 |
Why?
| Catalytic Domain | 4 | 2016 | 206 | 0.220 |
Why?
| Pregnancy | 4 | 2020 | 5694 | 0.210 |
Why?
| Molecular Docking Simulation | 4 | 2016 | 101 | 0.210 |
Why?
| MAP Kinase Kinase 1 | 2 | 2012 | 67 | 0.200 |
Why?
| Immune System | 1 | 2003 | 181 | 0.200 |
Why?
| Pleurotus | 1 | 2021 | 1 | 0.200 |
Why?
| src-Family Kinases | 4 | 2012 | 90 | 0.190 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2016 | 455 | 0.190 |
Why?
| Phosphorylation | 5 | 2021 | 1634 | 0.190 |
Why?
| Interleukin-33 | 2 | 2017 | 39 | 0.190 |
Why?
| Interleukin-7 Receptor alpha Subunit | 1 | 2020 | 11 | 0.180 |
Why?
| Membrane Proteins | 2 | 2021 | 1056 | 0.180 |
Why?
| Receptors, Prostaglandin | 1 | 2020 | 26 | 0.180 |
Why?
| Nitric Oxide | 2 | 2016 | 893 | 0.180 |
Why?
| Protein Binding | 7 | 2016 | 1975 | 0.180 |
Why?
| Protein Transport | 2 | 2013 | 412 | 0.180 |
Why?
| Hypersensitivity | 1 | 2003 | 270 | 0.180 |
Why?
| Carrier Proteins | 1 | 2004 | 726 | 0.180 |
Why?
| Enzyme Activation | 6 | 2012 | 828 | 0.180 |
Why?
| Immunologic Memory | 1 | 2021 | 313 | 0.170 |
Why?
| G2 Phase Cell Cycle Checkpoints | 2 | 2016 | 40 | 0.170 |
Why?
| Mitogen-Activated Protein Kinase 1 | 3 | 2010 | 173 | 0.170 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 2016 | 45 | 0.170 |
Why?
| Female | 16 | 2021 | 61588 | 0.170 |
Why?
| Receptors, Immunologic | 1 | 2020 | 209 | 0.170 |
Why?
| Colonic Neoplasms | 1 | 2021 | 224 | 0.170 |
Why?
| Interleukin-9 | 1 | 2017 | 11 | 0.160 |
Why?
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2017 | 24 | 0.160 |
Why?
| Adoptive Transfer | 3 | 2021 | 204 | 0.150 |
Why?
| Virulence Factors | 2 | 2016 | 140 | 0.150 |
Why?
| Endocytosis | 2 | 2009 | 156 | 0.150 |
Why?
| Immunization | 2 | 2018 | 412 | 0.150 |
Why?
| Lymphocyte Subsets | 1 | 2017 | 76 | 0.150 |
Why?
| Epigenesis, Genetic | 1 | 2021 | 539 | 0.150 |
Why?
| Yersinia | 1 | 2016 | 2 | 0.150 |
Why?
| Toluidines | 1 | 2016 | 5 | 0.150 |
Why?
| Carcinoma, Mucoepidermoid | 1 | 2016 | 16 | 0.150 |
Why?
| Rosaniline Dyes | 1 | 2016 | 10 | 0.150 |
Why?
| Enzyme Inhibitors | 3 | 2015 | 829 | 0.150 |
Why?
| Benzenesulfonates | 1 | 2016 | 23 | 0.150 |
Why?
| Enzyme Induction | 2 | 2014 | 94 | 0.150 |
Why?
| Acetylation | 2 | 2016 | 217 | 0.140 |
Why?
| Drug Resistance | 1 | 2017 | 167 | 0.140 |
Why?
| Caffeic Acids | 1 | 2016 | 2 | 0.140 |
Why?
| Yersinia enterocolitica | 1 | 2016 | 6 | 0.140 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2016 | 56 | 0.140 |
Why?
| Succinates | 1 | 2016 | 18 | 0.140 |
Why?
| Cell Cycle Checkpoints | 1 | 2016 | 87 | 0.140 |
Why?
| Microtubule Proteins | 2 | 2007 | 15 | 0.140 |
Why?
| Cell Culture Techniques | 2 | 2016 | 356 | 0.140 |
Why?
| Tubulin Modulators | 1 | 2015 | 10 | 0.140 |
Why?
| Ferrous Compounds | 1 | 2015 | 23 | 0.140 |
Why?
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2015 | 12 | 0.130 |
Why?
| Peroxides | 1 | 2015 | 21 | 0.130 |
Why?
| Reactive Nitrogen Species | 1 | 2015 | 25 | 0.130 |
Why?
| M Phase Cell Cycle Checkpoints | 1 | 2015 | 23 | 0.130 |
Why?
| Cell Line, Transformed | 1 | 2015 | 136 | 0.130 |
Why?
| Calcifediol | 1 | 2015 | 29 | 0.130 |
Why?
| Drug Synergism | 1 | 2016 | 339 | 0.130 |
Why?
| Cellular Senescence | 1 | 2016 | 151 | 0.130 |
Why?
| Doxorubicin | 1 | 2016 | 302 | 0.130 |
Why?
| Active Transport, Cell Nucleus | 2 | 2012 | 113 | 0.130 |
Why?
| Antibodies, Blocking | 1 | 2015 | 32 | 0.130 |
Why?
| Estrogen Receptor alpha | 1 | 2016 | 126 | 0.130 |
Why?
| Mucus | 2 | 2017 | 54 | 0.130 |
Why?
| Lipid Peroxidation | 1 | 2015 | 156 | 0.130 |
Why?
| Cytokinesis | 1 | 2015 | 46 | 0.130 |
Why?
| Transcription, Genetic | 2 | 2013 | 1323 | 0.130 |
Why?
| CD4 Lymphocyte Count | 2 | 2012 | 267 | 0.120 |
Why?
| Histones | 2 | 2016 | 552 | 0.120 |
Why?
| Lung | 2 | 2022 | 3666 | 0.120 |
Why?
| Muscle Fibers, Skeletal | 1 | 2016 | 192 | 0.120 |
Why?
| p38 Mitogen-Activated Protein Kinases | 3 | 2016 | 286 | 0.120 |
Why?
| Immune Tolerance | 2 | 2009 | 334 | 0.120 |
Why?
| Growth Inhibitors | 2 | 2012 | 43 | 0.120 |
Why?
| Vitamins | 1 | 2015 | 159 | 0.120 |
Why?
| Neoplasm Metastasis | 1 | 2016 | 544 | 0.120 |
Why?
| Molecular Dynamics Simulation | 4 | 2016 | 213 | 0.120 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2013 | 36 | 0.120 |
Why?
| Interleukin-4 | 2 | 2014 | 216 | 0.120 |
Why?
| Carcinogenesis | 1 | 2015 | 182 | 0.110 |
Why?
| Swine | 1 | 2016 | 731 | 0.110 |
Why?
| Biomarkers | 3 | 2020 | 3590 | 0.110 |
Why?
| Myristic Acids | 1 | 2012 | 9 | 0.110 |
Why?
| Myristic Acid | 1 | 2012 | 10 | 0.110 |
Why?
| Nuclear Receptor Co-Repressor 2 | 1 | 2012 | 14 | 0.110 |
Why?
| Nuclear Receptor Co-Repressor 1 | 1 | 2012 | 16 | 0.110 |
Why?
| DNA Damage | 1 | 2015 | 357 | 0.110 |
Why?
| Retinal Dystrophies | 1 | 2012 | 3 | 0.110 |
Why?
| Interleukins | 1 | 2015 | 242 | 0.110 |
Why?
| Pre-Eclampsia | 1 | 2015 | 183 | 0.110 |
Why?
| Severe Combined Immunodeficiency | 1 | 2012 | 21 | 0.110 |
Why?
| Novobiocin | 1 | 2012 | 5 | 0.110 |
Why?
| Proto-Oncogene Proteins c-raf | 1 | 2012 | 46 | 0.110 |
Why?
| Macrolides | 1 | 2012 | 57 | 0.100 |
Why?
| Pyrrolidinones | 1 | 2011 | 25 | 0.100 |
Why?
| Models, Biological | 2 | 2012 | 1715 | 0.100 |
Why?
| Tissue Engineering | 1 | 2016 | 363 | 0.100 |
Why?
| Endosomes | 2 | 2010 | 128 | 0.100 |
Why?
| Culture Media | 1 | 2011 | 163 | 0.100 |
Why?
| Cyclin-Dependent Kinases | 1 | 2012 | 111 | 0.100 |
Why?
| Triazoles | 1 | 2012 | 134 | 0.100 |
Why?
| Age of Onset | 1 | 2012 | 467 | 0.100 |
Why?
| Neutrophils | 1 | 2016 | 1233 | 0.100 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 1167 | 0.090 |
Why?
| Biosensing Techniques | 1 | 2011 | 107 | 0.090 |
Why?
| Enzyme Stability | 1 | 2010 | 75 | 0.090 |
Why?
| Eosinophils | 2 | 2012 | 283 | 0.090 |
Why?
| Actins | 2 | 2009 | 404 | 0.090 |
Why?
| Indoles | 1 | 2012 | 316 | 0.090 |
Why?
| Dynamins | 1 | 2009 | 30 | 0.090 |
Why?
| Ambrosia | 1 | 2009 | 7 | 0.090 |
Why?
| Gene Expression Profiling | 2 | 2013 | 1597 | 0.090 |
Why?
| Aspergillus | 1 | 2009 | 18 | 0.090 |
Why?
| Pyroglyphidae | 1 | 2009 | 17 | 0.090 |
Why?
| Th1 Cells | 1 | 2010 | 133 | 0.090 |
Why?
| Interleukin-2 | 1 | 2010 | 417 | 0.090 |
Why?
| Myosins | 1 | 2009 | 130 | 0.080 |
Why?
| Blotting, Western | 1 | 2011 | 1195 | 0.080 |
Why?
| Epithelial Cells | 2 | 2016 | 963 | 0.080 |
Why?
| RNA, Small Interfering | 2 | 2010 | 564 | 0.080 |
Why?
| Interleukin-10 | 1 | 2010 | 306 | 0.080 |
Why?
| Arthritis, Experimental | 1 | 2010 | 133 | 0.080 |
Why?
| Antigen Presentation | 1 | 2009 | 194 | 0.080 |
Why?
| eIF-2 Kinase | 1 | 2008 | 26 | 0.080 |
Why?
| Cytoskeleton | 1 | 2009 | 181 | 0.080 |
Why?
| Multiprotein Complexes | 1 | 2009 | 149 | 0.080 |
Why?
| Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.080 |
Why?
| Mitochondria | 1 | 2013 | 786 | 0.080 |
Why?
| HSP27 Heat-Shock Proteins | 1 | 2007 | 14 | 0.080 |
Why?
| Umbilical Veins | 1 | 2007 | 59 | 0.080 |
Why?
| GATA3 Transcription Factor | 2 | 2020 | 26 | 0.080 |
Why?
| Transfection | 2 | 2007 | 890 | 0.080 |
Why?
| Adult | 7 | 2021 | 31525 | 0.070 |
Why?
| Eye Proteins | 1 | 2007 | 77 | 0.070 |
Why?
| Chemotaxis, Leukocyte | 1 | 2007 | 133 | 0.070 |
Why?
| Inflammation Mediators | 1 | 2010 | 502 | 0.070 |
Why?
| Recombinant Proteins | 2 | 2015 | 1308 | 0.070 |
Why?
| Feedback | 1 | 2007 | 153 | 0.070 |
Why?
| Bronchi | 1 | 2008 | 242 | 0.070 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2008 | 299 | 0.070 |
Why?
| Rhinitis, Allergic, Perennial | 1 | 2006 | 23 | 0.070 |
Why?
| Neurons | 1 | 2014 | 1345 | 0.070 |
Why?
| Phosphoproteins | 1 | 2008 | 308 | 0.070 |
Why?
| Respiratory Mucosa | 1 | 2008 | 254 | 0.070 |
Why?
| Cloning, Molecular | 2 | 2004 | 546 | 0.070 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 175 | 0.070 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 2 | 2021 | 160 | 0.070 |
Why?
| Tyrosine | 1 | 2006 | 233 | 0.060 |
Why?
| Down-Regulation | 2 | 2021 | 627 | 0.060 |
Why?
| Middle Aged | 7 | 2021 | 27627 | 0.060 |
Why?
| Mice, Transgenic | 1 | 2010 | 2025 | 0.060 |
Why?
| Molecular Structure | 2 | 2016 | 459 | 0.060 |
Why?
| Flow Cytometry | 3 | 2014 | 1085 | 0.060 |
Why?
| Polymerase Chain Reaction | 1 | 2007 | 1012 | 0.060 |
Why?
| Cell Line | 3 | 2016 | 2707 | 0.060 |
Why?
| src Homology Domains | 1 | 2004 | 34 | 0.060 |
Why?
| Rats | 2 | 2010 | 5394 | 0.060 |
Why?
| Lung Neoplasms | 1 | 2016 | 2220 | 0.060 |
Why?
| Nerve Tissue Proteins | 2 | 2009 | 551 | 0.060 |
Why?
| Helminth Proteins | 1 | 2002 | 21 | 0.060 |
Why?
| Fibroblasts | 1 | 2007 | 843 | 0.050 |
Why?
| Antigen-Presenting Cells | 1 | 2003 | 156 | 0.050 |
Why?
| Kinetics | 2 | 2015 | 1625 | 0.050 |
Why?
| Alternaria | 1 | 2021 | 7 | 0.050 |
Why?
| Mutation | 1 | 2012 | 3457 | 0.050 |
Why?
| Severity of Illness Index | 3 | 2017 | 2674 | 0.050 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2006 | 1175 | 0.050 |
Why?
| Phytotherapy | 1 | 2021 | 69 | 0.050 |
Why?
| Heat-Shock Response | 1 | 2021 | 59 | 0.050 |
Why?
| Endothelium, Vascular | 1 | 2007 | 907 | 0.050 |
Why?
| Caenorhabditis elegans Proteins | 1 | 2002 | 192 | 0.050 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2020 | 147 | 0.040 |
Why?
| NIH 3T3 Cells | 2 | 2009 | 139 | 0.040 |
Why?
| Young Adult | 2 | 2010 | 10799 | 0.040 |
Why?
| B-Lymphocytes | 1 | 2003 | 770 | 0.040 |
Why?
| Respiratory Hypersensitivity | 1 | 2017 | 65 | 0.040 |
Why?
| Chemokines | 2 | 2009 | 230 | 0.040 |
Why?
| Dietary Supplements | 1 | 2021 | 467 | 0.040 |
Why?
| RNA | 1 | 2003 | 833 | 0.040 |
Why?
| Chaperonins | 1 | 2016 | 5 | 0.040 |
Why?
| Aged | 3 | 2010 | 19661 | 0.040 |
Why?
| Serum Amyloid A Protein | 1 | 2016 | 28 | 0.040 |
Why?
| Ubiquitination | 1 | 2016 | 87 | 0.040 |
Why?
| Complement C3a | 1 | 2016 | 33 | 0.040 |
Why?
| Child | 1 | 2016 | 19137 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 109 | 0.040 |
Why?
| Chlorogenic Acid | 1 | 2016 | 3 | 0.040 |
Why?
| Steroids | 1 | 2017 | 153 | 0.040 |
Why?
| Immunophenotyping | 1 | 2017 | 278 | 0.040 |
Why?
| Proteolysis | 1 | 2016 | 146 | 0.030 |
Why?
| Chronic Disease | 2 | 2015 | 1637 | 0.030 |
Why?
| Leukocyte Count | 1 | 2016 | 305 | 0.030 |
Why?
| Breeding | 1 | 2016 | 56 | 0.030 |
Why?
| Peracetic Acid | 1 | 2015 | 4 | 0.030 |
Why?
| Cell Extracts | 1 | 2015 | 17 | 0.030 |
Why?
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2015 | 14 | 0.030 |
Why?
| Yersinia pestis | 1 | 2015 | 34 | 0.030 |
Why?
| Enzyme Assays | 1 | 2015 | 23 | 0.030 |
Why?
| Respiratory Function Tests | 1 | 2017 | 526 | 0.030 |
Why?
| Plague | 1 | 2015 | 42 | 0.030 |
Why?
| Molecular Conformation | 1 | 2015 | 146 | 0.030 |
Why?
| Phenotype | 1 | 2003 | 3004 | 0.030 |
Why?
| Arachidonic Acid | 1 | 2015 | 122 | 0.030 |
Why?
| Cysteine | 1 | 2016 | 184 | 0.030 |
Why?
| Airway Remodeling | 1 | 2015 | 57 | 0.030 |
Why?
| Feedback, Physiological | 1 | 2015 | 75 | 0.030 |
Why?
| Lymphocyte Depletion | 1 | 2015 | 119 | 0.030 |
Why?
| Virulence | 1 | 2015 | 240 | 0.030 |
Why?
| Drug Interactions | 1 | 2015 | 352 | 0.030 |
Why?
| Adolescent | 2 | 2010 | 18483 | 0.030 |
Why?
| Bone Marrow Transplantation | 1 | 2015 | 244 | 0.030 |
Why?
| Carboxylic Acids | 1 | 2012 | 30 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2016 | 870 | 0.030 |
Why?
| Protein Structure, Tertiary | 1 | 2015 | 823 | 0.030 |
Why?
| Binding Sites | 1 | 2016 | 1224 | 0.030 |
Why?
| Bronchoscopy | 1 | 2014 | 247 | 0.030 |
Why?
| Dexamethasone | 1 | 2014 | 320 | 0.030 |
Why?
| Oxidation-Reduction | 1 | 2015 | 940 | 0.030 |
Why?
| Quantitative Structure-Activity Relationship | 1 | 2011 | 13 | 0.030 |
Why?
| Gene Silencing | 1 | 2012 | 177 | 0.030 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2012 | 193 | 0.030 |
Why?
| Stereoisomerism | 1 | 2011 | 93 | 0.030 |
Why?
| Models, Molecular | 1 | 2016 | 1435 | 0.020 |
Why?
| Male | 5 | 2021 | 57818 | 0.020 |
Why?
| Clonal Anergy | 1 | 2010 | 54 | 0.020 |
Why?
| Glucocorticoids | 1 | 2014 | 547 | 0.020 |
Why?
| Microarray Analysis | 1 | 2010 | 124 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2010 | 410 | 0.020 |
Why?
| Case-Control Studies | 1 | 2017 | 3173 | 0.020 |
Why?
| Cell Separation | 1 | 2010 | 296 | 0.020 |
Why?
| GTP Phosphohydrolases | 1 | 2009 | 69 | 0.020 |
Why?
| Placenta | 1 | 2015 | 641 | 0.020 |
Why?
| Chemokine CCL11 | 1 | 2008 | 22 | 0.020 |
Why?
| Bacteria | 1 | 2015 | 757 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 827 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2012 | 1158 | 0.020 |
Why?
| Autocrine Communication | 1 | 2008 | 42 | 0.020 |
Why?
| Algorithms | 1 | 2015 | 1543 | 0.020 |
Why?
| Antibody Specificity | 1 | 2008 | 184 | 0.020 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 155 | 0.020 |
Why?
| Disease Progression | 1 | 2015 | 2490 | 0.020 |
Why?
| Bone Marrow Cells | 1 | 2008 | 273 | 0.020 |
Why?
| Methacholine Chloride | 1 | 2006 | 48 | 0.020 |
Why?
| Bronchial Provocation Tests | 1 | 2006 | 54 | 0.020 |
Why?
| Dendritic Cells | 1 | 2009 | 442 | 0.020 |
Why?
| Nasal Mucosa | 1 | 2006 | 97 | 0.020 |
Why?
| Gene Expression | 1 | 2010 | 1492 | 0.020 |
Why?
| Blood Vessels | 1 | 2006 | 187 | 0.020 |
Why?
| Pulmonary Fibrosis | 1 | 2007 | 303 | 0.020 |
Why?
| Up-Regulation | 1 | 2007 | 872 | 0.010 |
Why?
| Receptors, Interleukin-5 | 1 | 2002 | 5 | 0.010 |
Why?
| Receptors, Interleukin | 1 | 2002 | 41 | 0.010 |
Why?
| Protein Kinase Inhibitors | 1 | 2008 | 811 | 0.010 |
Why?
| DNA Primers | 1 | 2002 | 533 | 0.010 |
Why?
| Comorbidity | 1 | 2006 | 1527 | 0.010 |
Why?
| Prevalence | 1 | 2006 | 2326 | 0.010 |
Why?
| Base Sequence | 1 | 2002 | 2160 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 2002 | 2073 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2002 | 2873 | 0.010 |
Why?
|
|
Gorska's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|